Azoospermia Treatment in Gurgaon

Azoospermia means no sperm are detected in the ejaculate on two separate semen analyses. It affects approximately 1% of all men and 10–15% of men presenting with infertility. It does not always mean no sperm exist in the body. Obstructive azoospermia (OA) - where sperm are produced but blocked - has excellent treatment outcomes. Non-obstructive azoospermia (NOA) - where sperm production is impaired - can still yield sperm in 40–60% of cases using MicroTESE. The key is accurate diagnosis before assuming nothing can be done.

Obstructive azoospermia (OA): sperm production is normal but outflow is blocked - due to vasectomy, epididymal blockage (post-infection), absent vas deferens (CBAVD), or ejaculatory duct obstruction. FSH is typically normal, testicular size is normal, and sperm can be retrieved by PESA or TESA. Pregnancy rates with IVF-ICSI using retrieved sperm are excellent. Non-obstructive azoospermia (NOA): sperm production itself is impaired - due to Klinefelter syndrome (47,XXY), Y-chromosome microdeletions, hormonal failure, chemotherapy, or idiopathic causes. FSH is often elevated, testes may be small. MicroTESE can retrieve sperm in 40–60% of cases.

MicroTESE (microdissection TESE) uses an operating microscope to examine the testicular tissue directly and identify dilated seminiferous tubules - the ones more likely to contain sperm - rather than taking random biopsy cores. This approach retrieves more sperm, removes far less testicular tissue, and causes significantly less post-operative testosterone decline than conventional TESE. Success rates for NOA are 40–60% with MicroTESE versus 16–45% with conventional TESE. For men with NOA, MicroTESE is the internationally recommended approach and Dr. Nitin's preferred technique.

A complete workup includes: two semen analyses (both must show zero sperm on centrifuged sample). Hormones: FSH, LH, testosterone, prolactin, inhibin B - these distinguish OA from NOA. Karyotype (chromosomal analysis): to detect Klinefelter syndrome (47,XXY) or other chromosomal abnormalities. Y-chromosome microdeletion analysis: AZFa, AZFb deletions predict no sperm will be found at MicroTESE (AZFa or AZFb deletion = MicroTESE not recommended). AZFc deletion: partial sperm production may still be present. Scrotal and transrectal ultrasound: assess testicular volume, detect ejaculatory duct obstruction or absent vas. Testicular biopsy: only if needed to confirm maturation arrest or Sertoli-cell-only syndrome.

Hormonal treatment is beneficial in specific cases: hypogonadotrophic hypogonadism (low FSH and LH causing low testosterone) responds dramatically to gonadotropin injections - sperm may appear in the ejaculate after 3–12 months of treatment, avoiding the need for surgical sperm retrieval. This is a reversible, treatable cause that must not be missed. Post-chemotherapy or radiation-induced azoospermia occasionally recovers spontaneously or with hormonal support - semen analysis should be repeated at 12 and 24 months before considering sperm retrieval surgery. Idiopathic NOA does not reliably respond to empirical hormone treatment; MicroTESE is the primary option.

Sperm retrieved at MicroTESE can be used fresh for same-day IVF-ICSI (intracytoplasmic sperm injection) with your partner's eggs, or cryopreserved (frozen) for future IVF cycles. Cryopreservation is often preferred as it allows the female partner's ovarian stimulation to be optimised separately. IVF-ICSI success rates using testicular sperm depend on female partner age and ovarian reserve, sperm quality retrieved, and the fertility centre's laboratory capabilities. Dr. Nitin coordinates closely with IVF centres for optimal timing and sperm handling.

Yes - in approximately 40–50% of cases. Klinefelter syndrome (47,XXY) is the most common chromosomal cause of male infertility and azoospermia, but focal areas of sperm production may persist in the testicle. MicroTESE can retrieve sperm in approximately 40–50% of Klinefelter men, particularly before age 35 and when testosterone levels have been optimised. The retrieved sperm are used for IVF-ICSI. Genetic counselling is recommended beforehand, as there is a small increased risk of sex chromosome abnormalities in offspring (though preimplantation genetic testing can screen for this).